The financial metrics for GlaxoSmithKline plc presented below are for the financial year 2021.
PEG
                -0.91
                Trailing Price/Earnings To Growth Ratio
            EV/Sales
                3.82
                Enterprise Value To Sales Ratio
            EBIT/EV
                0.04
                EBIT To Enterprise Value Ratio
            EV/EBITDA
                16.2
                Enterprise Value to EBITDA Ratio
            D/E
                3.84
                Debt To Equity Ratio
            ROE
                29.59%
                Return On Equity
            ROIC
                14.77%
                Return On Invested Capital
            DPR
                91.2%
                Dividend Payout Ratio
            Current Ratio
                0.79
                Current Liquidity Ratio
            EPS Growth
                -27.57%
                Earnings Per Share Growth Rate
            Graham Number
                $18.34
                Benjamin Graham's Number
            Piotroski Score
                N/A
                Piotroski F-Score
            Beta
                N/A
                Beta Coefficient Value